4//SEC Filing
REXAHN PHARMACEUTICALS, INC. 4
Accession 0001140361-17-002733
$IRDCIK 0001228627operating
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 5:42 PM ET
Size
7.4 KB
Accession
0001140361-17-002733
Insider Transaction Report
Form 4
Ahn Chang Ho
DirectorChairman & CEO
Transactions
- Award
Restricted Stock Units
2017-01-20+70,000→ 70,000 total→ Common Stock (70,000 underlying) - Award
Stock Option (right to buy)
2017-01-20+330,000→ 330,000 totalExercise: $0.18Exp: 2027-01-20→ Common Stock (330,000 underlying)
Footnotes (3)
- [F1]One quarter of the option vests and becomes exercisable on January 20, 2018, and, thereafter, 1/36th of the remaining option vests in equal installments on the first business day of each month until fully vested.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]The restricted stock units vest in four equal annual installments on the last business day in February, beginning February 28, 2018.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001228627
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 5:42 PM ET
- Size
- 7.4 KB